CAM
INSP icon

Concorde Asset Management’s Inspire Medical Systems INSP Stock Holding History

Concorde Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,098
Closed -$227K – 214
2021
Q1 		$227K Buy
+1,098
New +$233K 0.13% 186
2020
Q4 		– Sell
-9,363
Closed -$1.21M – 171
2020
Q3 		$1.21M Buy
+9,363
New +$1.03M 0.69% 37

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Concorde Asset Management's INSP Position: Q2 2021 in Review

Concorde Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2021, closing a stake of 1,098 shares — an estimated $227K sold.

Concorde Asset Management first reported a position in INSP in Q3 2020 and held it in 2 quarters. The position peaked at $1.21M in Q3 2020. 247 funds tracked by Wall St. Rank hold INSP as of Q2 2021.

  • Concorde Asset Management reported no remaining Inspire Medical Systems position as of Q2 2021 after selling out during the quarter.
  • Concorde Asset Management sold 1,098 Inspire Medical Systems shares in Q2 2021, an estimated $227K.
  • Concorde Asset Management first reported a position in Inspire Medical Systems in Q3 2020 and held it in 2 quarters.
  • Concorde Asset Management's Inspire Medical Systems position peaked at $1.21M in Q3 2020.
  • 247 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2021.

Based on Concorde Asset Management's 13F filing for Q2 2021, filed 20 Jul 2021.